Luxury's recovery is real. It is also very narrow
Kering posted second-quarter revenue of 3.652 billion euros, up 2% like-for-like, its first positive quarter after twelve quarters of decline, though Gucci remained slightly negative.
- Published
- 4 September 2026
- Reading time
- 1 min
- Topics
- AI, Consumer Health, Retail
- Written by
Bloom Partners Team

Kering posted second-quarter revenue of 3.652 billion euros, up 2% like-for-like, its first positive quarter after twelve quarters of decline, though Gucci remained slightly negative. LVMH's 19.52 billion euros showed 3% organic growth, with Fashion & Leather Goods returning to +1% after seven consecutive quarters of decline, while the recurring operating margin sat at 22.5% amid sluggish Chinese demand and pricing pressure across the aspirational segment. Hermes grew 6% at constant rates in the first half. At the very top, the pattern is clearer still: Brunello Cucinelli raised its full-year growth forecast to 10 to 11% on sustained full-price demand, which the company attributes to controlled distribution and limited exposure to aspirational consumers. Underneath the numbers, a structural clear-out is under way: LVMH sold Marc Jacobs to a WHP Global and G-III joint venture, and Kering sold its entire beauty division to L'Oreal for 4 billion euros. A recovery that arrives at the top and at the value end but not in the middle is not a recovery; it is a bifurcation. The aspirational consumer was never really a segment. It was an assumption that people on the way up would keep trading up. When that assumption breaks, brands built on it have to decide which customer they are actually for. Cucinelli's outperformance is not a story about craftsmanship. It is a story about never having taken the middle in the first place. (Glossy)
More insights
4 September 2026Article
Nvidia is buying the place where open-source AI lives
Nvidia has reportedly agreed to buy Hugging Face for $12.9 billion, according to The Information, though Business Insider, which first reported the takeover interest, put the valuation above $13 billion and cautioned that no agreement had yet been signed.
1 min read
4 September 2026Article
P&G paid $3.8 billion for permission to speak clinically
P&G is acquiring Thorne from L Catterton for $3.8 billion, building out its Personal Health Care division alongside brands such as Metamucil, Align and New Chapter, in what is now a run of high-profile supplement acquisitions this year.
1 min read
Don’t want to miss what comes next?
Bloom Bites brings the thinking behind our work to your inbox, usually before it turns into an article. One mail, no noise, unsubscribe in a click.

